Author response: Hippo pathway-mediated YAP1/TAZ inhibition is essential for proper pancreatic endocrine specification and differentiation
Yifan Wu(Central South University), Pei Wang(Nanchang University), Michael H Nipper(The University of Texas at San Antonio Health Science Center), Kunhua Qin(Tianjin Medical University), Janice Deng(The University of Texas at San Antonio Health Science Center), Logan R Ramjit(The University of Texas at San Antonio Health Science Center), H. Efsun Arda(National Institutes of Health), Jun Liu(Jinan University), Yi Xu(The University of Texas at San Antonio Health Science Center), Xue Yin(Hangzhou Red Cross Hospital), Kevin Lopez(The University of Texas at San Antonio Health Science Center), Zhenqing Ye(The University of Texas at San Antonio Health Science Center), Yu Luan(The University of Texas at San Antonio Health Science Center), Truong Vo(Cancer Institute (WIA)), Shreya Rajhans(Cancer Institute (WIA))
Cited by 0
Related Papers
Targeted Delivery of CRISPR/Cas9‐Mediated Cancer Gene Therapy via Liposome‐Templated Hydrogel Nanoparticles
|Advanced Functional Materials|2017|297
Progression of Vascular Calcification and Clinical Outcomes in Patients Receiving Maintenance Dialysis
|JAMA Network Open|2023|116
Unphosphorylated STAT3 modulates alpha7 nicotinic receptor signaling and cytokine production in sepsis
|European Journal of Immunology|2010|114
The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes
|Scientific Reports|2015|110